Siemens Healthineers AG Share Price

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 15:54:26 28/05/2024 BST 5-day change 1st Jan Change
53.99 EUR +0.35% Intraday chart for Siemens Healthineers AG +1.05% +2.62%

Financials

Sales 2024 * 22.68B 24.64B 1,929B Sales 2025 * 24.26B 26.36B 2,063B Capitalization 60.03B 65.22B 5,105B
Net income 2024 * 2.02B 2.2B 172B Net income 2025 * 2.56B 2.79B 218B EV / Sales 2024 * 3.18 x
Net Debt 2024 * 12.2B 13.26B 1,038B Net Debt 2025 * 10.51B 11.42B 894B EV / Sales 2025 * 2.91 x
P/E ratio 2024 *
29.8 x
P/E ratio 2025 *
23.4 x
Employees 71,000
Yield 2024 *
1.9%
Yield 2025 *
2.3%
Free-Float 23.56%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.35%
1 week+1.05%
Current month+3.61%
1 month+2.35%
3 months-1.64%
6 months+5.10%
Current year+2.62%
More quotes
1 week
53.20
Extreme 53.2
54.46
1 month
49.20
Extreme 49.2
54.46
Current year
49.20
Extreme 49.2
58.14
1 year
44.39
Extreme 44.39
58.14
3 years
40.32
Extreme 40.32
67.66
5 years
28.50
Extreme 28.5
67.66
10 years
28.50
Extreme 28.5
67.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 31/12/17
Director of Finance/CFO 57 31/12/17
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 31/10/22
Director/Board Member 57 22/03/21
Director/Board Member 72 28/02/18
More insiders
Date Price Change Volume
28/05/24 53.96 +0.30% 248 176
27/05/24 53.8 +0.22% 208,051
24/05/24 53.68 -0.04% 377,872
23/05/24 53.7 -0.52% 443,256
22/05/24 53.98 +1.05% 485,336

Delayed Quote Xetra, May 28, 2024 at 03:39 pm

More quotes
Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
53.8 EUR
Average target price
60.47 EUR
Spread / Average Target
+12.39%
Consensus